As we demonstrated that TRPM8 activation inhibited PCa cell trans–endothelial migration, LNC–WS12s could also represent an efficient strategy to target the extravasation of circulating tumor cells if TRPM8 expression is maintained in these cells. The gene discussed is TRPM8; the disease is neoplasm.